The product is the real deal. I think CYDY has gr
Post# of 148187
That is what is so frustrating about the BLA delays. I'm less worried about getting to revenue and more interested in reaching credibility. Obviously BTD for cancer would deliver a stunning amount of credibility in an instant.
I think it is very possible that CYDY's management fails to fully capture all the potential of leronlimab for shareholders but they would have to really screw up to not capture at least 2-3 billion.